Implementation of Hepatitis B screening to reduce the risk of viral reactivation in gynecologic oncology patients at a regional cancer center

Implementation of Hepatitis B screening to reduce the risk of viral reactivation in gynecologic oncology patients at a regional cancer center

  • Profile Photo
    Marie Pinard 31 May 2022

    Sarah & team, this is great work. Excellent use of QI methodology to achieve a desired performance against a best practice. 0 to 70% is pretty impressive. The annotated control chart provided a nice overview of the multiple interventions used to achieve the aim. Do you think one (or more) of the numerous interventions was the "secret sauce"? It looks like perhaps the standardization of the protocol/integration within the workflow coupled with the feedback had the biggest impact. Will the team be monitoring this process going forward? Will the target remain 70% or is the plan to increase the target? The poster was really nicely laid out and the recorded explanation was really easy to follow. Thank you for sharing this great work.

  • Profile Photo
    Sarah J. Mah 07 June 2022

    Marie- thank you for your feedback and reviewing our work! I would agree that designing a one-step protocol and then integrating it into existing tasks (triage, chemotherapy ordering) seemed to have the highest impact. The next steps at our institutional level have been shaken up by our transition to the EPIC EMR system which means that workflow and ordering are now completely different, but the project has gained interest and momentum across other oncologic specialties and we are now in the process of designing an algorithm for screening across all disease sites and how to build it into our new EPIC order sets. If the screening is built into the routine chemotherapy order sets, screening targets may be raised to 100%-- the more important next question will be follow-up, adherence, and whether positive results can trigger appropriate management in a timely fashion.

  • Profile Photo
    Marie Pinard 10 June 2022

    Thank you Sarah. It's very exciting to hear about a build within Epic as well as continued efforts to better understand outcomes and fidelity. Great work.

Presenter
Sarah J. Mah

Sarah Mah is a Gynecologic Oncology fellow at McMaster University who completed her MSc in Quality Improvement and Patient Safety through the University of Toronto Institute of Health Policy, Management and Evaluation. She completed her residency at the University of British Columbia.

Share
Total Views 20

CQUIPS+ support

Questions or comments about CQUIPS+?
Connect with us at communications@cquips.ca

Copyright © 2022 CQUIPS+. All rights reserved.